Ken Griffin Tela Bio, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.32 - $5.04 $2,784 - $6,048	1,200 Added 15.58%	8,900 $22,000
Q2 2024 Aug 14, 2024	BUY	$4.39 - $6.36 $32,925 - $47,700	7,500 Added 3750.0%	7,700 $36,000
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $1,060 - $1,522	200 New	200 $1,000
Q3 2023 Nov 14, 2023	SELL	$7.85 - $10.68 $785 - $1,068	-100 Reduced 1.45%	6,800 $54,000
Q2 2023 Aug 14, 2023	BUY	$9.23 - $11.23 $58,149 - $70,749	6,300 Added 1050.0%	6,900 $69,000
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $5,646 - $7,218	600 New	600 $6,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $52.9M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.